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Abstract
The study of expression quantitative trait loci (eQTL) is a powerful way of detecting transcriptional regulators at a genomic
scale and for elucidating how natural genetic variation impacts gene expression. Power and genetic resolution are heavily
affected by the study population: whereas recombinant inbred (RI) strains yield greater statistical power with low genetic
resolution, using diverse inbred or outbred strains improves genetic resolution at the cost of lower power. In order to
overcome the limitations of both individual approaches, we combine data from RI strains with genetically more diverse
strains and analyze hippocampus eQTL data obtained from mouse RI strains (BXD) and from a panel of diverse inbred strains
(Mouse Diversity Panel, MDP). We perform a systematic analysis of the consistency of eQTL independently obtained from
these two populations and demonstrate that a significant fraction of eQTL can be replicated. Based on existing knowledge
from pathway databases we assess different approaches for using the high-resolution MDP data for fine mapping BXD
eQTL. Finally, we apply this framework to an eQTL hotspot on chromosome 1 (Qrr1), which has been implicated in a range
of neurological traits. Here we present the first systematic examination of the consistency between eQTL obtained
independently from the BXD and MDP populations. Our analysis of fine-mapping approaches is based on ‘real life’ data as
opposed to simulated data and it allows us to propose a strategy for using MDP data to fine map BXD eQTL. Application of
this framework to Qrr1 reveals that this eQTL hotspot is not caused by just one (or few) ‘master regulators’, but actually by a
set of polymorphic genes specific to the central nervous system.
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Introduction
Understanding how genetic variability affects molecular phe-
notypes is important for revealing the molecular mechanisms
underlying physiological phenotypes such as complex diseases [1].
Genome-wide measurements of RNA expression levels as
molecular phenotypes have been correlated to genetic variation
in a variety of biological contexts [2–6]. Such data are used for the
identification of expression quantitative trait loci (eQTL), i.e.
genomic regions whose genotype is correlated with the RNA
expression in a panel of genetically diverse individuals [7]. The
underlying assumption is that such eQTL regions contain direct or
indirect regulators of the target gene in question.
The considerable advances in eQTL studies notwithstanding,
there are still open questions about the biology and applications of
eQTL mapping [8]. One persistent challenge in the field is the
selection of loci and genes that should receive further biological
investigation. For instance, eQTL are often only poorly repro-
ducible across studies [9]. The difficulty to reproduce eQTL (and
other genetic associations) is partly explained by differences
between the study populations: different populations have different
genetic backgrounds, which may considerably alter the phenotypes
associated with a given allele. Secondly, the genome-wide
measurement of RNA levels is noisy, which may result in many
spurious eQTL. Finally, because of the large number of statistical
hypotheses tested in eQTL studies (all genes versus all markers)
such studies notoriously suffer from high false-positive rates unless
stringent controls for multiple testing are applied.
In order to overcome these problems, recent studies have
combined different model populations in their studies, thereby
enhancing genetic resolution, power of the study and reproduc-
ibility of the findings [10,11]. The reproducibility of eQTL in two
populations of closely related mice, BXD recombinant inbreds (RI)
[12] and an F2 cross between the same parental strains has been
reported to be high [13]. However, it is not clear to which extend
eQTL will replicate in more diverse panels within the same
species. Recently, Gatti et al. [10] compared mouse liver eQTL
from BXD RI lines and inbred strains of the Mouse Diversity
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eQTL replicate with greater frequency than trans-eQTL, although,
a systematic, quantitative assessment of the extent of consistency
between the two datasets is lacking.
Another major problem of current eQTL studies is the correct
identification of the causal genes. Due to linkage disequilibrium,
several genes can be near each marker making it difficult to
identify which of the genes are the causal factors responsible for
the observed expression phenotype. While linkage studies in F2 or
recombinant inbred (RI) lines are thought to have reasonable
statistical power, the limited number of recombination events in
such crosses produces large QTL intervals that make the selection
of candidate genes difficult. One approach that has been used to
narrow individual QTL intervals is in silico haplotype mapping in
laboratory inbred strains [14,15]. Other approaches utilize
additional, independent information such as protein interaction
data in order to identify causal genes [16–18]. For a single
phenotype, several methods have been described to combine QTL
data from different crosses [19,20]. However, due to the high cost
of replicating a large eQTL study and the computational issues of
combining data for thousands of transcripts, these methods are
difficult to apply to most eQTL studies. Using genetically more
diverse populations has the advantage that a higher density of
informative genetic markers can be achieved, which potentially
increases the mapping resolution. Unfortunately, those studies
often suffer from poor statistical power [21].
Thus, it has been suggested that eQTL obtained from
populations with greater genetic diversity, such as the MDP,
should be combined with RI population-based data [10,11,22].
The underlying idea is to use the RI population-based data for
identifying potentially causal loci and then use the high-resolution
data for ‘fine mapping’ the causal gene. While there is evidence
that this data integration helps in identifying causal genes, a
systematic analysis of its potential has not been performed. It
remains to be shown that high- and low-density eQTL data are
consistent and that combining them aids the robust identification
of truly causal genes.
In order to address these open questions, we investigated the
reproducibility and fine mapping of eQTL based on BXD RI lines
[23] and inbred strains of the MDP [21]. We measured
hippocampus gene expression in 28 strains from the MDP and
compared and integrated those data with corresponding eQTL
data from the BXD panel [24]. We systematically show
consistency between the two datasets for a wide range of eQTL
thresholds and discuss various strategies to integrate high- and
low-resolution eQTL data for fine mapping purposes. We assessed
those data integration schemes for fine mapping by quantifying the
ability of each method to reproduce known functional associations
between genes. Finally we used the MDP-based data to improve
the genetic dissection of a brain-specific eQTL hotspot on distal
Chromosome 1 [25].
The actual density of markers is not the limiting factor for the
genotype resolution in the two populations. While, BXD and
MDP have been genotyped at virtually the same markers, the
smaller number of recombination events in the BXD population
creates larger chromosomal regions that are inherited from the
same parent. Consequently, few markers are actually informative;
that is, several adjacent markers carry the same information about
the origin of a particular genomic region. In the remainder of this
text we use the terms ‘MDP markers’ and ‘BXD markers’ to
denote those markers that are informative in the respective
populations. Note that the majority of BXD markers are part of
the MDP markers (3055 out of 3791, 80%).
Results and Discussion
Consistency between MDP and BXD eQTL datasets
An overview of eQTL datasets considered in this study is
provided in Table 1. In order to investigate the reproducibility of
eQTL between independent mouse populations, we compared the
number of eQTL common between the MDP and BXD datasets
to the number of common eQTL obtained with randomized data.
All 25,173 probesets with unique genomic locations shared
between the BXD and MDP datasets were included in this
comparison. We tested two strategies comparing the eQTL scores:
the exact comparison directly compares the scores of common
markers, whereas the interval mapping integrates the information
from several (high-resolution) MDP markers near (low resolution)
BXD markers (Figure 1, Table 2). At very high quantile cutoffs
(99.99% or higher) between 1% and 2% (65–165) of the BXD
eQTL could be replicated in the MDP population. Even though
this is only a small fraction of all eQTL, the overlap is much larger
than expected by chance (genome-wide comparison; Fisher’s exact
test p-value at 99.99% quantile cutoff: ,1610
24 for the exact
comparison, 5610
24 for the interval comparison).
Next, we extended the consistency analysis over a continuous
range of thresholds. Figure 1 shows the fraction of common eQTL
as a function of both the BXD and MDP eQTL scores. In order to
show the significance of the overlap we compared the fractions of
overlapping eQTL resulting after randomizing the data. We
binned BXD and MDP eQTL scores, thereby establishing a two-
dimensional grid of the two scoring schemes. Each bin in this grid
contains eQTL with scores comparable within BXD and within
MDP data. For the randomization we shuffled the BXD and MDP
scores within each bin by re-assigning them to different target
genes. We then compared the number of ‘common’ eQTL in each
Table 1. Overview of eQTL datasets used.
Dataset BXD eQTL dataset MDP eQTL dataset
Experimental source Overall et al. [24] This study
a
Genetic reference panel BXD Mouse Diversity Panel (MDP)
Number of strains 71 28
Number of microarrays 201 28
Number of markers 3,791 101,104
Number of probe sets 45,101 44,922
eQTL detection method QTL Reaper [13] Haplotype Association Mapping (HAM) [51]
aGenomics Institute of the Novartis Research Foundation (San Diego, CA, USA).
doi:10.1371/journal.pone.0013920.t001
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that the overlap expected by chance is substantially smaller than
the observed overlap for a wide range of thresholds.
The fraction of common signals in the actual measurements is
always higher than the shuffled one, both in the exact and interval
comparison schemes. In the interval scheme, the average number
of common peaks is approximately three times higher, but the
signal-to-noise ratio – i.e. the difference between the fraction of
correct and shuffled comparisons – is smaller over the entire range
of thresholds. Hence, the interval mapping yields a higher
recovery at the cost of lower specificity (more false positives).
Figure 2 shows the genomic distribution of common eQTL after
the exact comparison at the 99.5% quantile cutoff (1,071 matches
with comparison p-values below 0.05). The matrix of common
eQTL in Figure 2a shows that local (cis-) eQTL are much more
reproducible than distant (trans-)eQTL. The majority of common
eQTL localizes at the diagonal or in its immediate vicinity. Local
eQTL linking a target gene to its own locus are assumed to be due
to polymorphisms acting in cis, e.g. in the promoter of the gene
(hence the name cis-eQTL). Distant eQTL, on the other hand, are
due to polymorphisms in genes other than the target gene. Such
trans-eQTL exerts its effect through variable activity of a regulator
controlling the target. The overrepresentation of cis-eQTL in
Figure 2 is consistent with the fact that, in general, cis-eQTL tend
to produce stronger statistical associations than trans-eQTL [26]
and are easier to reproduce [10,13].
For each marker we computed the number of eQTL common
between BXD and MDP (‘common eQTL frequency’, CEF).
Plotting the CEF across the genome (Figure 2b) indicated a non-
random distribution with some hotspots along the genome (black
bars). Among these eQTL-hotspots is a well-studied hotspot on
chromosome 1 [25]. To assess the significance of these hotspots,
we randomized the data in two different ways: first by shuffling
marker positions and second by randomizing probeset assign-
ments. The first randomization shuffled the assignment of eQTL
to genomic positions (i.e. markers), yielding global p-values for the
observed frequencies (dotted red lines in Fig. 2b). In the second
scheme, we randomized the probe set assignment of the eQTL at
each locus, i.e. eQTL from MDP were compared against random
probesets from BXD. This second approach accounts for the fact
that some loci have large numbers of eQTL, which may yield large
CEF simply by chance. However, the shuffled values generally
yield few common eQTL (the real values are higher than the
shuffled values in 39 out of the 44 peaks shown in Figure 2b). In
some cases the number of observed overlapping eQTL is much
higher than expected by chance (e.g. on chromosomes 1, 4, 8, 11
and 19). However, when less strict eQTL thresholds are used, we
could observe a similar genomic distribution of CEF for correct
and shuffled comparisons (data not shown). This suggests that
several trans-bands observed at high-confidence thresholds are
common to MDP and BXD and are of biological significance.
This is an important finding, as eQTL-hotspots are often
spuriously identified due to batch-effects or population sub-
structure [27–29]. Since the hotspots in Figure 2 were reproduced
in two different populations they are much less likely to be
artifactual. Taken together, these observations suggest that the
MDP and BXD eQTL are consistent, that high-scoring eQTL can
be reproduced and that several eQTL hotspots are conserved
across the two mouse panels.
Integration of MDP and BXD eQTL data for fine mapping
Given the high statistical significance of the overlap between the
two populations, we sought to use the high-resolution MDP data
for fine mapping causal genes in loci that are significant according
to the BXD panel. Given a locus with several candidate genes, we
wanted to use the MDP data to refine the identification of the
causal gene. Here we considered a situation where a marker is
strongly linked to some target gene based on the BXD data. All
genes between the two flanking markers from the BXD dataset are
putative transcriptional regulators. The higher density of infor-
mative markers in the MDP population may help to select the
most likely causal gene.
In order to assess the performance of the MDP-based fine
mapping, we decided to restrict the analysis to eQTL with very
strong association signals in both the BXD and MDP datasets (see
Materials and Methods). Application of our selection criteria
yielded a list of 105 suitable eQTL intervals, which we
subsequently used for assessing the MDP-based fine mapping.
We scored the performance of our fine mapping based on whether
the selected gene from the locus is annotated as a member of the
same pathway as the target gene. Using the pathway annotation
from the Kyoto Encyclopedia of Genes and Genomes (KEGG) we
quantified the number of suggested causal genes being annotated
for the same pathway as the target gene of the respective eQTL
(see Materials and Methods for details). This assessment is based
on the assumption that the source gene (i.e. the QT gene) and the
Table 2. Consistency of eQTL datasets.
Quantile cut-off 0.99 0.999 0.9999 0.99995
Number of selected eQTL (BXD) 956,272 95,468 9,545 4776
Number of selected eQTL (MDP) 25,357,555 (953,407)
a 2,523,474 (95,121) 252,525 (9,605) 126,068 (4,801)
Number of common eQTL (NC) 5,897 (8,295) 416 (572) 106 (165) 65 (101)
Fraction of NC with P-value ,=0.05 49.0% (34.5%) 100% 100% 100%
NC/NBXD
b 0.006 (0.0087) 0.0044 (0.006) 0.011 (0.017) 0.014 (0.021)
aValues in parentheses refer to interval comparison.
bNC, number of common eQTL; NBXD, number of selected eQTL in BXD dataset.
doi:10.1371/journal.pone.0013920.t002
Figure 1. Consistency between MDP and BXD eQTL datasets. Average fraction of common eQTL signals, FC=mean(NHITS/(NMDP+NBXD)),a sa
function of BXD and MDP signal detection thresholds. The exact comparison (left) compares signals at identical markers in the two populations,
whereas the interval comparison (right) summarizes the MDP values in proximity of BXD markers. Top panels: actual measurements. Middle
panels: shuffled comparisons (10 randomizations). Bottom panels: difference between real and shuffled data for exact and interval comparison.
doi:10.1371/journal.pone.0013920.g001
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Hence, methods yielding a higher enrichment for genes being
members of the same pathway gain higher credibility. According
to this criterion causal genes should rank high (be on top of the list)
when sorted based on the MDP eQTL. Figure 3a shows that
MDP-based fine mapping ranks functionally related genes higher
in the list than expected by chance (top 50%: 63 cases; bottom
50%: 29 cases; not ranked: 13 cases). Figure 3b shows that genes
from the same pathway are significantly more often ranked highest
when using the MDP-based mapping as opposed to picking the
gene closest to the BXD marker or a random gene from the locus.
When using the MDP data the pathway members rank highest in
Figure 2. Co-localizing common eQTL between MDP and BXD datasets. The top 0.5% of all eQTL of the two datasets were compared using
the ‘exact’ comparison and common eQTL are shown. A: matrix of common eQTL. X-axis shows marker positions and y-axis shows target gene
positions. Each dot corresponds to an eQTL common between the two studies. B: Number of common eQTL across the genome within 1320 equally
sized bins of 2 Mb. Black bars report the number of common eQTL in each bin, whereas the red error bars represent the mean number and standard
deviation of hits in each bin obtained after shuffling the probesets (10 randomizations). Horizontal red lines represent global p-values obtained after
shuffling bin positions. Results are shown for bins with at least 5 common eQTL.
doi:10.1371/journal.pone.0013920.g002
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closest to the BXD marker (Sc) and 10% when choosing a random
gene from the locus (SR). These numbers include several cis-eQTL,
hence, in those cases the causal and target gene are identical.
However, since our fine-mapping algorithm did not consider
location information about target genes, there is no particular
advantage (or bias) for resolving causal genes in cis-eQTL regions
except for the fact that cis-eQTL in general tend to be stronger. In
order to demonstrate that the enrichment of true causal genes is
independent of cis-eQTL we hence repeated the analysis excluding
all cis-eQTL (Figure S1). Due to the weaker eQTL signals we did
in fact observe a decrease of the overall performance when
exclusively looking at trans-eQTL. Yet, using the MDP data for
fine mapping still significantly improved the identification of causal
genes. Thus, even though the MDP data do not always correctly
predict the most likely causal gene, the data substantially improve
the gene selection.
Generally, we rank the genes within each locus based on MDP
markers positioned inside the transcribed region of the genes.
However, in cases when no MDP marker is located in the
Figure 3. Integration of MDP and BXD eQTL data for fine mapping. A: Distribution of the ranking results for 105 selected eQTL intervals with
strong association signals in both the BXD and MDP datasets. The x-axis shows the number of candidate genes at each locus and the y-axis shows the
rank (scaled between 0 and 1) of genes that are in common pathways with the target genes. Thus, each eQTL interval is represented as a point of
coordinates (RK,N G) where RK is the rank of the (presumed) causal gene from the KEGG pathway and NG is the number of genes within the interval.
Circle sizes are proportional to the number of eQTL. Pathway co-members rank significantly above random when using the MDP data as additional
information for scoring candidate genes. B: Assessment of MDP-based candidate gene selection. For each of the 105 selected loci a selected
candidate gene was considered as a true positive if it is part of a common pathway with the target gene. The figure shows the fraction of loci with
correct selections. Bars show results when ranking genes based on their MDP scores for different values of the ext parameter (see schema on the
right), using full locus and restricted locus sizes (i.e. loci are restricted to 0.5 cM around the BXD marker). Horizontal lines show true positive rates for
random selections (SR) and selecting the closest gene (SC). Black lines: ‘closest gene’ success rate (SC) and random success rate (SR) for full locus sizes.
Grey lines: SC and SR for restricted locus sizes (rls).
doi:10.1371/journal.pone.0013920.g003
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proximity of the genes. If there is no marker in the proximity of a
gene that gene remains unscored and it is not considered as a
causal gene (see Materials and Methods for details). The definition
of this ‘search region’ is a critical parameter that affects the
prioritization of genes within a locus, as demonstrated in Figure 3b.
When the search region is too small, many genes remain unscored
and are thus not ranked, yielding a high false negative rate. If, on
the other hand, the search region is too large, markers are
considered that are too far away from the respective gene and thus
unlikely to correctly map the genotype of the gene.
In addition, we observed a correlation between the strength of
MDP eQTL scores and their ability to correctly map causal genes.
Figure S2 indicates that the consideration of lower-scoring eQTL
yields smaller fractions of pathway members that are ranked first.
The fact that the performance deteriorates at lower scores
underlines once more that the consistency of high MDP scores
with pathway membership is not by chance. Thus, high-scoring
MDP eQTL can be used for improving the detection of causal
genes; however, weaker MDP scores should be used with caution.
Defining the locus
If no additional information is available, one has to assume that
the genetic variation causing the phenotypic change (i.e.
expression change) may be located anywhere between the two
markers neighboring the linked marker [30]. However, if the
genetic distance between the linked marker and the flanking
markers is large, it is less likely that the causal genetic variation is
far away from the linked marker (i.e. close to the flanking markers).
Thus, in order to further improve the causal gene identification it
may be useful to only consider genes at a limited genetic distance
away from the linked marker.
For testing this hypothesis we limited the set of genes considered
at a given locus by a maximal genetic distance (see Materials and
Methods for details). We defined eQTL intervals via genetic
distances expressed in centimorgans (cM) in order to restrict
interval sizes and the number of genes associated with each
selected marker. Then we re-ran the fine mapping analysis as
described before at different DcM (0.1, 0.3, 0.5, 0.7, 1, 1.5, .1.5),
while simultaneously varying the search region around each gene.
Figure 3b and Figure S3 show that restricting the locus size yields
consistently better results as opposed to considering all genes
between the flanking markers. Optimal performance was obtained
with 0.5 cM.
Using MDP eQTL to dissect an eQTL hotspot on distal
Chromosome 1
Several eQTL studies with intercross or RI strains have
observed that many distant eQTL map to the same location on
a chromosome, giving rise to what is known as eQTL hotspots or
trans-bands [24,31,32]. In general, the presence of eQTL hotspots
suggests either the presence of a master regulator gene which
controls the expression of groups of genes together or the presence
of several tightly linked genes within the hotspot, each of which
regulates the expression of a subset of genes mapping to this locus
[31,33,34]. Here we illustrate how the MDP eQTL dataset can be
used to improve the resolution at a previously studied hotspot on
distal chromosome 1. This analysis consists of two major parts: first
we performed the MDP-based fine mapping as outlined above on
a small set of eQTL with very high BXD and MDP eQTL. This
analysis identified 14 local eQTL that could be reproduced in the
MDP population and it identified high-confidence causal genes. In
the second part we relaxed the criteria for inclusion of MDP
eQTL in order to identify functional enrichment of genes mapping
to sub-regions of Qrr1.
The distal part of mouse chromosome 1, (172.5–177.5 Mb)
harbors 16 BXD markers and 122 known genes (Mouse Genome
NCBI m37). It is also known as Qrr1, ‘‘QTL-rich region on
chromosome 1’’, as it contains a large number of previously
identified QTLs for behavioral traits, including open field activity
[35], fear conditioning [36], rearing behavior [37], and other
measures of emotionality [38,39]. In addition to behavioral
phenotypes, a number of other metabolic, physiological and
immunological traits have been repeatedly mapped to this region
[25]. Of particular interest is the association between Qrr1 and the
response to a wide range of neuroactive drugs [40–43].
Fine mapping Qrr1
Qrr1 can be broadly divided into a gene-rich proximal part
(Qrr1p, 172.5–174.5 Mb) and a relatively gene-sparse distal part
(Qrr1d, 174.5–177.5 Mb). Recently, Mozhui et al. [25] revealed
multiple distinct loci in Qrr1 that regulate gene expression
specifically in the central nervous system (CNS). In particular,
they focused on Qrr1d and proposed Fmn2, Rgs7 and a cluster of
tRNAs as strong candidate regulators of this distal part of Qrr1.
However, due to the limited resolution, they could not subdivide
transcripts that map to Qrr1p into smaller functional modules.
Based on the fact that Qrr1 has 254 informative markers in the
MDP dataset we expected that incorporating the MDP-based
eQTL in the analysis might further resolve the structure of this
region. We first selected targets with strong BXD eQTL in Qrr1,
and then examined the same set of target transcripts in MDP to
better refine their eQTL positions. In BXD, there are 307 genes
with maximal LOD scores on markers located in Qrr1. In order to
obtain a set of high-confidence Qrr1 target genes we filtered 205
genes having eQTL above the 99.9% quantile (of the entire eQTL
matrix) for the subsequent analysis. In BXD, this cutoff
corresponds to transcripts with a minimum LOD score of 4
(genome-wide p-value of approximately 0.01). In order to apply
the fine-mapping procedure described above we further filtered
this list for targets with MDP scores above the 99.9% quantile (37
eQTL).
Of the 182 BXD eQTL, 22 have a local eQTL in Qrr1 and 11
of these local eQTL could be replicated in MDP (Table S1).
Importantly, in 4 of those cases the maximum MDP score was at
the target gene itself and in the remaining 7 cases it was very close
(,500 kb) to the target gene. This suggests that most or even all of
the causal mutations in Qrr1 act in cis.
The MDP-based fine-mapping further identified 26 trans-eQTL
mapping to 14 putative regulators (or QT genes) in Qrr1. Only 4 of
these regulators do not have a cis-eQTL themselves (Apoa2, Fcgr2b,
Olfr220, Hsd17b7). However, upon closer inspection we noticed
that all four of the candidate QT genes had another gene with a
cis-eQTL nearby (,100 kb, see Table S1 for details). Hence, if
these other genes were causing the respective eQTL, all causal
genes in Qrr1 would be affected in cis.
In order to further corroborate these candidate regulators, we
integrated independent gene expression information. Mozhui et al.
[25] had already shown that the Qrr1 is specific for the CNS.
Hence, we suspected that the genes causing the transcript variation
of Qrr1 target genes should be specifically expressed in the CNS. In
order to confirm this hypothesis we checked whether genes with
cis-eQTL are more specifically expressed in the CNS than others,
which indeed is the case (Figure 4). However, the 4 candidate
regulators without cis-eQTL only have poor CNS specificity of
their expression (Figure 4) rendering them even less likely to be
truly causal. Whatever the true QT genes are in these cases, we
Low- and High-Resolution eQTL
PLoS ONE | www.plosone.org 7 November 2010 | Volume 5 | Issue 11 | e13920can conclude that most eQTL in Qrr1 are ultimately caused by cis
effects, since virtually all high-significance eQTL could be
associated with a gene having a cis-eQTL.
For the remaining analysis we relaxed the MDP eQTL
threshold in order to increase the coverage, i.e. we considered
all eQTL with an MDP eQTL above the 95% quantile (182
eQTL, the BXD cutoff was not changed). The larger number of
eQTL considered allows us to assess whether eQTL target genes
are enriched for known target genes or for certain functional
categories. Figure 5 shows the location of MDP markers in Qrr1
along with the respective number of target genes per marker. This
analysis revealed an intricate sub-structure of Qrr1: there are
distinct sub-regions having significantly larger numbers of target
genes than other regions of Qrr1. Importantly, Figure 5 reveals that
Qrr1 consists of several eQTL hotspots. The fact that Qrr1 harbors
several causal genes is also supported by the robust detection of 11
local QTL in both mouse populations.
Usf1 regulates many Qrr1 target genes
Qrr1 encodes two transcription factors, Atf6 and Usf1, while only
the latter has a significant number of eQTL mapping to it. Hence,
we set out to validate whether Usf1 might be truly causal for these
eQTL. Usf1 is an essential transcription factor encoded in Qrr1p
(approximately 173.35 Mb, Figure 5). Plaisier et al. [44] had
measured the genome-wide response to over-expressing Usf1. This
data provides independent experimental validation of Usf1 target
genes. Overall, there are 50 Qrr1 target genes confirmed with the
BXD eQTL data (Fisher’s exact test p-value=8610
26). Assuming
that Usf1 is actually causal for several eQTL, we hypothesized that
its target genes should be enriched among eQTL mapping close to
Usf1. Hence, we used this notion to assess the resolution obtainable
with the MDP data. In Figure 5c, the enrichment of known Usf1
target genes (Fisher’s exact test) is reported as a function of the
physical distance from the transcription factor, i.e. the length of an
exploratory interval centered on Usf1. A significant enrichment
occurs within 300 kb from the gene; this result is confirmed by
repeating the analysis at different thresholds in the BXD and MDP
datasets, as well as different cutoffs for defining targets from the
over-expression experiment (Figure S4). In order to demonstrate
the specificity of this finding, we repeated the analysis with a non-
candidate transcription factor in Qrr1 (Atf6) with an associated
dataset of differentially expressed genes after over-expressing Atf6
[46]. Only 13 transcripts could be mapped in this case (Fisher’s
exact test p-value=0.02), without enrichment in target genes at
the Atf6 locus (Figure S4). These results confirm that a mapping
resolution of a few hundred kilobases is achievable with the MDP
data. Many of the Usf1 target genes mapping to this locus may be
indirectly affected by the Usf1 allele, i.e. they are not directly
regulated via Usf1 binding in their enhancer regions [44]. To
address this question and to further validate our conclusions we
utilized Usf1 DNA binding data measured with ChIP-Chip in
human hepatocytes [45]. Binding of Usf1 was detected for 22
orthologous genes mapping to Qrr1, 13 of which mapped to the
Usf1 locus (within 300 kb). This is a highly significant enrichment
(Fisher’s exact test p-value ,0.004), demonstrating that many of
the genes affected by the Usf1 polymorphism might in fact be
direct Usf1 targets.
Target genes mapping to Qrr1 sub-regions are
functionally distinct
Provided that several causal genes contribute to the trans-eQTL
observed in Qrr1 we reasoned that different parts of this region
Figure 4. CNS expression specificity of candidate regulators in Qrr1. CNS specificity of expression is expressed as t-test statistics comparing
expression in CNS tissues against all tissues tested. Box plots show distributions of t-scores for genes mapping to Qrr1. cis (BXD): subset of genes
with a cis-eQTL in BXD; cis (BXD+MDP): genes with a cis-eQTL in both BXD and MDP; no cis: genes localized in Qrr1 but without a cis-eQTL;
Candidates without cis: candidate causal genes (distant eQTL only) without a cis-eQTL.
doi:10.1371/journal.pone.0013920.g004
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genes mapping to different loci in Qrr1 should be enriched for
different functions. To test this hypothesis we selected functional
categories that are significantly enriched among Qrr1 target genes
compared to the rest of the genome and checked whether those
categories are enriched among target genes mapping to specific
sub-regions of Qrr1. A complete list of all functional categories
considered can be found in Table S2. In order to resolve marker-
specific enrichment of functional classes, we computed the
average MDP eQTL score at each marker for all genes of a
specific class. This analysis was repeated in two different ways:
first with all genes from a functional class with a significant BXD
eQTL and secondly for the subset having a significant MDP
eQTL as well. However, both approaches yielded comparable
Figure 5. Using MDP eQTL to dissect an eQTL hotspot on distal Chromosome 1. A: Overview of candidate regulators number of eQTL
mapping to Qrr1. Vertical bars show the number of target genes per marker in MDP (for every gene, the strongest eQTL in MDP within Qrr1 is
selected). Labels at the bars illustrate enriched functional categories. Genes encoded in Qrr1 are shown at the bottom (top: forward strand, bottom:
reverse strand). The color gradient reflects CNS expression specificity (t-statistic). Green triangles indicate cis-eQTL in the BXD dataset, whereas blue
triangles represent a cis-eQTL detected in both BXD and MDP datasets. B: Detail of Qrr1p around 173 Mb. Labels of selected genes are shown. C:
Enrichment of Usf1 targets along Qrr1. Black line: enrichment (-logp) as a function of physical distance from the transcription factor, i.e. the length of
an exploratory interval centered on Usf1. Red lines show results for randomized Usf1 targets (Solid red line: average across 100 randomizations;
dotted red lines: average 6 standard deviation).
doi:10.1371/journal.pone.0013920.g005
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of Qrr1 are enriched for targets from specific functional classes,
some of which are indicated in Figure 5. See Figure S5 for a
complete overview.
Several mitochondrial genes have eQTL mapping between
172.7 and 173.3 Mb in Qrr1; ten of these genes possess a
mitochondrial transit peptide, which is required for transport of
the proteins across the mitochondrial membrane. Two candidate
QT genes encoded in this small region, Shdc and Tomm40l, also
localize to the mitochondria. In particular, Tomm40l is a channel-
forming protein implicated in the import of protein precursors into
mitochondria and interacts with mitochondrial targeting sequenc-
es [47]. Interestingly, the genes with transit sequences have trans-
eQTL that map within 200 kb of Tomm40l, suggesting that this
gene might in fact be causal for the eQTL mapping to this sub-
region.
Amino acid-tRNA synthetases (ARS) are also significantly
enriched among Qrr1 target genes [25], but at a different locus.
A locus at 173.3 Mb appears to be particularly important for
amino acid metabolism, as seven ARS, four amino acid
transporters and three other genes involved in amino acid
biosynthesis map to it. Mohzui et al. [25] proposed a tRNA
cluster in Qrr1 as a functionally pertinent candidate for the tRNA
synthetases. However, in BXD almost all ARS transcripts map to
the distal part of Qrr1, where very few tRNAs can be found. Using
the MDP data, the ARS genes map within 300 kb of the major
tRNA cluster in Qrr1 (25 tRNAs between 172.95 and 173.05 Mb,
reported in the tRNAscan-SE Genomic tRNA database [48]). As
mentioned above, genes mapping near 173.2 Mb are also
enriched among Usf1 targets. They include four ARS (Aars, Cars,
Yars, Mars), two transferases (Dpm1, B4Galt3), an amino acid
transporter (Slc6a20a) and an amino acid synthetase (Asns). Two of
the genes – B4Galt3 and Ppox – are also genes with cis-eQTL in
Qrr1. These observations imply that either the tRNAs or Usf1 (or
both) might be causal for the expression variation among this set of
amino acid metabolism related genes.
Another coherent set of eQTL could be observed for potassium
transporters in the short interval from Atp1a2 to Kcnj10 (174.2–
174.3 Mb). This locus has been associated with seizure suscepti-
bility (Szs1) [49] and the two potassium channel genes encoded
there – Kcnj9 and Kcnj10 – were proposed as primary candidates.
The MDP data revealed that nearly all potassium transporters in
our set map precisely to this locus - Kcnj9 and Kcnj10 as cis-eQTLs,
Kcnv and Kctd4 as trans-eQTLs. This underlines the importance of
the Szs1 locus for fine control of potassium ion homeostasis within
the hippocampus and CNS tissues in general.
Rgs7 might act in trans inside Qrr1
As opposed to many other candidate regulators in Qrr1, Rgs7
(regulator of G-protein signaling 7) has several target genes
mapping to its promoter (177.42–177.53 Mb) and not in its
transcribed region (Figure 5a). RGS proteins are important
regulators of G-protein mediated signal transduction. Rgs7 is
predominantly expressed in the brain and has been found to
shuttle between the cytoplasmic membrane and the nucleus, thus
playing a role in gene expression in response to external stimuli
[50]. Therefore, it is likely that Rgs7 influences the expression of
genes belonging to diverse functional categories. Although we
could not discern a single functional class of genes trans-regulated
by Rgs7, our data suggests that Rgs7 is a master regulator in this
region controlling other genes encoded in Qrr1 in trans (Table S1).
These genes have various functions and include Ndufs2 (a
mitochondrial NADH dehydrogenase), Wdr42a (a scaffolding
protein expressed in the brain) and Pex19 (a protein necessary
for early peroxisomal biogenesis). Besides being targets of eQTL
linking to Rgs7, Wdr42a and Pex19 also have strong local eQTL in
both BXD and MDP. The fact that some of the genes proposed as
candidate regulators in Qrr1 are simultaneously trans-regulated by
Rgs7 may suggest a complex, multi-layered regulatory landscape in
Qrr1 where Rgs7 could be involved in fine tuning of the main
transcriptional response mediated by those genes.
Conclusions
Integration of low- and high-resolution eQTL data is a feasible
strategy for computational fine mapping of causal genes. For a
given low-resolution locus, the availability of several strong signals
from a high-resolution eQTL dataset facilitates the refinement of a
causal locus to specific genes.
We found several factors that influence fine mapping when
using high-resolution eQTL data: the intensity of high-resolution
eQTL signals, the way eQTL intervals are defined and the
search/ranking scheme used and its specific parameters. Our
analysis of Qrr1 demonstrates that further integration of biological
data greatly improves the overall performance of the prediction
method.
Our work suggests, in accordance with previous analyses [25]
that the Qrr1 trans-band is not caused by just one master regulator,
but is due to several polymorphic genes that either independently
or in a concerted way affect the expression of numerous target
genes. Based on the additional power gained from our own data
and because of the higher resolution of the MDP data we could
identify 11 local QTL with very high confidence. The analysis of
functional enrichment in sub-regions of Qrr1 further corroborates
the conclusion that Qrr1 in fact consists of several trans-bands.
The MDP and BXD datasets are different in several respects.
Not only are the study populations different, but the experiments
were performed independently in two different labs. Because of
this, our examination of consistency implicitly assesses the
reproducibility of eQTL between labs. However, because the lab
effect is confounded with the genetic difference of the populations
we cannot distinguish these two effects. In addition, we used a
different eQTL mapping method that is more suitable for
mapping QTL in the MDP population [51]. We are currently
working on mapping methods that are equally suitable to low- and
high-density QTL data, though the results of our work show that a
significant overlap between eQTL sets can already be achieved
even if the mapping methods are not the same.
Bennett et al. [11] have recently published a study where they
measured QTL in different RI panels and MDP lines. This
certainly is the ideal situation, because the data obtained for the
different populations are more consistent if measured under
identical conditions in one lab. On the other hand, a very large
number of physiological, behavioral and molecular QTL has
already been measured for the BXD panel (see www.genenetwork.
org). Our analysis demonstrates that it is possible to combine these
existing data with newly obtained trait data from other populations
for fine-mapping the QTL. Integrating new and existing data
considerably improves the insight beyond analyzing either of the
two datasets alone.
Materials and Methods
Details about the eQTL datasets used in this study are listed in
Table 1. All gene expression data were obtained from hippocam-
pus samples using the same microarray platform (Affymetrix
Mouse Genome 430 2.0). All position data in this study are set to
the NCBI Mouse Genome Build 37.1 (UCSC mm9, July 2007).
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All animals received humane care according to the criteria
outlined in the ‘‘Guide for the Care and Use of Laboratory
Animals’’ prepared by the National Academy of Sciences and
published by the National Institutes of Health (NIH). All animal
experiments performed at GNF were approved by its Institutional
Animal Care and Use Committee (IACUC). GNF’s vivaria are
accredited by the Association for Assessment and Accreditation of
Laboratory Animal Care International (AAALAC), approval
number 001051.
MDP eQTL – Tissue Acquisition and Sample Preparation
Mice used in this study cover the following 28 inbred strains:
129S1/SvlmJ, A/J, AKR/J, BALB/cByJ, BTBR T+ tf/J, BUB/BnJ,
C3H/HeJ, C57BL/6J, C57BR/cdJ, C58/J, CBA/J, CE/J, DBA/2J,
FVB/NJ, I/LnJ, KK/HIJ, MA/MyJ, MRL/MpJ, NOD/LtJ, NON/
LtJ, NZO/HILtJ, NZW/LacJ, P/J, PL/J, RIIIS/J, SM/J, SWR/J
and WSB/EiJ. Hippocampus was collected from male mice, ages
8–11 weeks, between the hours of 9 AM and noon. The anterior
hippocampus was not collected. Coronal cuts were made at
approximately 1.8 and 3.8 mm posterior from Bregma. A spatula
was used to remove cortex and any tissue ventral to the
hippocampus. Samples were immediately placed on dry ice.
Frozen samples were homogenized in Trizol (Life Technologies),
and resulting total RNA was cleaned using RNeasy columns
(Qiagen). Total RNA from 3 mice were pooled and one
microarray was used for each pool. The Affymetrix One Cycle
kit was used to make cRNA from total RNA. Array hybridization,
washing, and scanning followed standard Affymetrix protocols.
eQTL Mapping
It has been reported that sequence polymorphisms in probe
regions may cause many false cis-eQTL, as they lead to differences
in hybridization, and not in gene expression [52]. A recent, high
quality set of SNPs has been used to correct BXD gene expression
data (about 7 million SNPs generated by sequencing C57BL/6J
and DBA/2J genotype strains, using SOLiD and Solexa short
sequence reads – R.Williams et al., unpublished data - www.
genenetwork.org). The M430 2.0 probes in the BXD eQTL
dataset containing one or more SNPs have been removed.
For the BXD panel, eQTL associations have been inferred
using Haley-Knott regression [53], which is equivalent to the
original publication of the BXD data [24].
MDP expression data have been corrected for SNPs in probe
regions using available data at dbSNP 126 (May 2006). MDP
eQTL mapping was performed using methods that have been
previously described [54]. Briefly, we use ANOVA to calculate the
strength of genetic associations between an input phenotype and
the ancestral haplotype structure (as inferred using a local window
of three adjacent SNP alleles across the genome). A weighted
bootstrap method was introduced to detect association peaks
conditional on the population structure in the MDP [21]. At each
genetic locus, the association score (Sa) was represented as the
negative log10-transformed p-value. HAM analysis was performed
for all differentially expressed genes across the 28 strains.
Expression phenotypes were in log scale.
eQTL Comparison Strategy
Since the MDP dataset has a higher density of informative
markers than the BXD dataset, there is not a simple 1:1
relationship between the markers. Hence, two comparison
schemes have been tested: exact and interval-based. The exact
scheme only uses markers that are common to the two datasets
(i.e. at common genomic positions, 65 bp). Thus, MDP markers
that are between two informative markers from the BXD cross are
ignored. The interval scheme integrates all markers of the
MDP study within some interval around the markers from the
BXD population. In this case we assign the MDP markers to the
closest BXD marker and compare the maximum MDP signal of
those markers to the respective BXD signal. For both schemes,
multiple common peaks within a 5 Mb window are only counted
once [21].
We determine the significance of two matching eQTL peaks
based on an empirical distribution of eQTL scores. First, we
discretized the range of scores for both the MDP and BXD data
(above the 99% quantile), which establishes a two-dimensional
grid of the two scoring schemes. Then, for each threshold
combination (i.e. each bin), a background distribution is
established using 10
4 random eQTL profile comparisons and
counting the number of matching eQTL.
Genomic Locations – Local and Distant eQTL
In order to identify local (cis-) eQTL and distant (trans-) eQTL
we mapped the probe sets (Affymetrix Mouse 430 2.0) to the
corresponding genomic locations (NCBI Mouse Genome Build
m37.1). Local eQTL have been defined as eQTL within 5 Mb of
the physical location of the gene itself [21,22]. Using shorter
intervals for defining local eQTL did not significantly change the
conclusions (not shown). For the study of Qrr1, a smaller threshold
(500 kb) has been used to define local eQTL.
To search for the presence of common co-localizing distant
eQTL (eQTL hotspots, or trans-bands), the entire genome was
divided into 2 Mb bins (1320 total bins) and the number of
significant distant eQTL (in common between the MDP and BXD
datasets) was counted in each bin.
eQTL Fine Mapping Assessment
We used independent, external gene annotations to test the
efficiency of our methods for fine mapping of loci to specific causal
genes. This approach is based on the assumption that genes whose
products participate in the same molecular pathway are also likely
to influence each other’s expression levels [55]. Hence, a candidate
source gene of some eQTL is assumed to be correct if both the
candidate and target gene are members of the same KEGG
pathway (KEGG release 49.0 [56]). We ran the eQTL fine
mapping for 3969 unique mouse genes being annotated as KEGG
pathway members.
Selection of Significant eQTL Intervals for the Fine
Mapping Analysis
For every marker mi within the low-resolution eQTL dataset
(BXD), we defined its associated eQTL interval as the genomic
region delimited by the flanking markers (mi21,m i+1). For assessing
the performance of MDP-based fine mapping, we decided to
restrict the analysis to intervals with strong association signals in
both the BXD and MDP datasets. Thus, we selected eQTL
intervals matching all of the following criteria:
1. BXD eQTL signal $99.99% quantile in BXD eQTL dataset,
genome-wide;
2. MDP eQTL signal $99.99% quantile in MDP eQTL dataset,
genome-wide;
3. Number of genes within the eQTL region .1;
4. Number of MDP (high resolution) eQTL signals .1;
5. The target gene is annotated as a member of at least one
KEGG pathway;
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of the same KEGG pathway.
The first two criteria ensure that the loci contain high BXD and
MDP signals. Using MDP data for fine mapping does not make
sense if criteria 3 and 4 are not fulfilled. The last two criteria
restrict the analysis to eQTL with sufficient prior knowledge. The
final selection included 105 eQTL intervals that confirmed with
the above criteria and hence could be used for subsequent analysis.
Scoring Candidate Genes
We reformulate the fine-mapping task as follows: Given a
genomic interval around a marker that is significant according to
the BXD data, the task is to rank the genes within this interval
based on the MDP data. We then evaluate the ranking based on
the known pathway memberships. We assigned a score to each
gene in the interval based on the MDP scores as follows:
N If there is at least one marker in the transcribed region of the
gene, use the maximum of those markers.
N If there is no marker in the transcribed region, use the
maximum score of the flanking markers. The genomic region
that is searched in this case extends symmetrically downstream
and upstream the transcribed region and is defined by a fixed
length in bp (specified by the parameter ‘ext’).
Subsequently, genes in each search interval were ranked based
on those MDP scores and the top ranking gene was selected as the
predicted causal gene. If this top-ranking gene is in a common
KEGG pathway with the target gene, the ranking is called a
‘success’. We then compute the fraction of correct predictions
among all N intervals assessed, SHR=Nsuccesses/N, where Nsuccesses is
the number of correct predictions.
This score is then compared to:
N the expected random success rate, which is the average
frequency of ‘‘true’’ causal genes in the N cases:
Srandom~
P
fi
N
,f~
NTrueCausalGenes
NGenes
;
N the success rate Sclosest obtained by selecting the closest gene to
the low-resolution (BXD) marker.
Use of Genetic Distances to Narrow Locus Sizes
We used genetic distances from Mouse HS genetic map-Build
37 available at the Wellcome Trust Center for Human Genetics
(http://www.well.ox.ac.uk/mouse). Mapping of MDP known
markers to the HS genetic map provides 9,843 markers with
genetic distances. We then used this information to specify eQTL
intervals in terms of genetic distances (DcM) instead of base pairs,
in order to restrict interval sizes (and number of genes) associated
with each selected eQTL. When genetic distance was not available
for the interval under study, we assumed this parameter to vary
linearly with physical distance for small intra-marker regions
(typically few hundred kb). Hence, we retrieved cM value by
means of linear interpolation between the two closest markers with
known genetic distance.
Usf1 and Atf6 Over-expression Datasets
Plaisier et al. [44] studied overexpression of Usf1 in HEK293T
cells in vitro to ascertain the genes downstream of Usf1 (GEO
accession: GSE17300). CEL files from the repository were
processed as described in [44]. Differential expression between
Usf1 and empty vector control transfected cells was analyzed using
a Student’s t-test. Differentially expressed genes were selected at
different p-value cutoffs (0.1, 0.05, 0.001); p#0.05 was used for the
enrichment illustrated in Fig. 5c; additional cutoffs are reported in
Figure S4. Human genes were mapped to murine genes using the
available orthology data at Mouse Genome Informatics (MGI
4.32, December 2009; http://www.informatics.jax.org).
For Atf6, overexpression was studied in mouse heart tissue [46]
(GEO accession: GSE8311). We selected 607 genes exhibiting at
least 2-fold differential expression (p#0.001).
Analysis of Tissue Specificity in Gene Expression
The GNF Mouse GeneAtlas V3 was used as an independent
source of information about tissue-specific gene expression. In this
dataset, 78 tissues were taken from naı ¨ve male C57BL6 mice for
hybridization to MOE 430-2 arrays [57] (https://biogps.gnf.org).
CNS-specific gene expression was evaluated by testing the
distribution of expression levels in the CNS (11 tissues) against
the distribution of expression levels across all tissues included in
GeneAtlas (two-sided Student’s t-test). Tissue-specific expression
levels were averaged in case of genes targeted by multiple
probesets.
Functional Enrichment Analysis
Enrichment in functional categories was evaluated using the
analytical tool DAVID 6.7 (http://david.abcc.ncifcrf.gov) [58].
Overrepresented functional terms were identified and statistical
significance of enrichment was calculated using a modified Fisher’s
Exact Test or EASE score [59].
Supporting Information
Table S1 Regulators (quantitative trait genes) for Qrr1 as
suggested by MDP mapping data.
Found at: doi:10.1371/journal.pone.0013920.s001 (0.05 MB
DOC)
Table S2 Functional enrichment analysis of genes that map to
Qrr1 in the BXD hippocampus data set.
Found at: doi:10.1371/journal.pone.0013920.s002 (0.02 MB
XLS)
Figure S1 Assessment of MDP-based candidate gene selection -
trans-eQTL only. For each of the selected loci a selected candidate
gene was considered as a true positive if it is part of a common
pathway with the target gene. The figure shows the fraction of loci
with correct selections; x-axis shows inclusion of successively more
eQTL intervals at decreasing MDP scores (between top 100 and
top 300 strongest signals). Black line: true positive rate (TPR) using
MDP signals. Blue line: TPR using the closest gene. Solid red line:
TPR using random gene selection (average across 100 random-
izations). Dotted red lines: average TPR for random gene selection
6 standard deviation. We also confirmed that genes being part of
the same pathway rank significantly higher when using the MDP
data for fine-mapping (analysis equivalent to Figure 3A). We
focused on the top 200 intervals without cis-eQTL. Candidate
genes from the same pathway were ranked among the top 50% in
87 cases and among the bottom 50% in 67 cases (46 cases not
ranked; difference is significant with p,10
216, one-sided t-test).
Found at: doi:10.1371/journal.pone.0013920.s003 (0.00 MB
PDF)
Figure S2 Correlation between the strength of MDP eQTL
scores and their ability to correctly map causal genes. The eQTL
intervals are ordered according to decreasing MDP eQTL scores,
e.g. longer lists include lower scores.
Found at: doi:10.1371/journal.pone.0013920.s004 (0.00 MB
PDF)
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DcM.
Found at: doi:10.1371/journal.pone.0013920.s005 (0.13 MB
PDF)
Figure S4 Enrichment of Usf1 targets along Qrr1 at different
thresholds in the BXD and MDP datasets, and different p-value
cutoffs for defining targets from the over-expression experiment.
A: lower p-value cutoff (0.1, 5839 targets); B: higher p-value cutoff
(0.01, 850 targets); C: lower BXD threshold (99.5% percentile, 285
genes selected); D: higher MDP threshold (99.9% percentile, 37
genes selected). E: Enrichment of Atf6 targets along Qrr1. Black
line: enrichment (-logp) as a function of the physical distance from
the transcription factor, i.e. the length of an exploratory interval
centred on Atf6. Red lines show results for randomized Atf6
targets (average across 100 randomizations 6 standard deviation).
Found at: doi:10.1371/journal.pone.0013920.s006 (0.39 MB
PDF)
Figure S5 Functional enrichment of target genes linking to
Qrr1. The average MDP eQTL score at each marker in Qrr1 is
reported for all genes of a specific class.
Found at: doi:10.1371/journal.pone.0013920.s007 (0.84 MB
PDF)
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